文献速递神经肿瘤

幕上脑胶质瘤手术中使用神经导航的效果:一项队列研究

Effects of the Use of Neuronavigation in Patients with Supratentorial Brain Gliomas: A Cohort Study.
PubMed 文献 · World Neurosurg · 2024-05-09

该回顾性队列研究纳入2016年7月至2022年9月在两家医院接受胶质瘤手术的110例患者,其中79例使用神经导航。神经导航使全切除率提高57%(使用组56% vs 未使用组35.5%,RR 1.57,P=0.056),术后神经功能缺损发生率降低79%(12% vs 33.3%,RR 0.21,P=0.0003),但对IV级胶质瘤患者生存期的改善无统计学意义(15个月 vs 13.8个月,OR 0.19,P=0.13)。

要点

  • 神经导航使胶质瘤全切除率提高57%(56% vs 35.5%,RR 1.57,P=0.056)。
  • 神经导航使术后神经功能缺损发生率降低79%(12% vs 33.3%,RR 0.21,P=0.0003)。
  • 神经导航对IV级胶质瘤患者生存期无显著影响(15个月 vs 13.8个月,OR 0.19,P=0.13)。

核心结论

  • 神经导航改善了脑胶质瘤手术的有效性(更高的肿瘤全切除率)和安全性(更少的神经功能缺损)。
  • 然而,神经导航对IV级胶质瘤患者的生存期无显著影响。

研究设计与样本

  • 回顾性队列研究,评估2016年7月至2022年9月在Dr. Alejandro Dávila Bolaños军事医院和巴塞罗那诊所医院接受胶质瘤手术患者的电子记录数据。
  • 共纳入110例患者,其中79例使用神经导航接受手术。
  • 根据是否使用神经导航分析并比较术前和术后临床及影像学特征。

主要发现

  • 神经导航使使用组全切除率提高57%;使用神经导航手术的患者中全切除率为56%,而未使用神经导航手术的患者中为35.5%(风险比[RR] 1.57;P=0.056)。
  • 使用神经导航后术后神经功能缺损(暂时性和永久性)发生率降低79%(12% vs 33.3%;RR 0.21;P=0.0003)。
  • 神经导航改善了IV级胶质瘤患者的生存期(15个月 vs 13.8个月),但无统计学显著性(比值比[OR] 0.19;P=0.13)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite the growing acceptance of neuronavigation in the field of neurosurgery, there is limited comparative research with contradictory results. This study aimed to compare the effectiveness (tumor resection rate and survival) and safety (frequency of neurological complications) of surgery for brain gliomas with or without neuronavigation. METHODS: This retrospective cohort study evaluated data obtained from electronic records of patients who underwent surgery for gliomas at Dr. Alejandro Dávila Bolaños Military Hospital and the Clinic Hospital of Barcelona between July 2016 and September 2022. The preoperative and postoperative clinical and radiologic characteristics were analyzed and compared according to the use of neuronavigation. RESULTS: This study included 110 patients, of whom 79 underwent surgery with neuronavigation. Neuronavigation increased gross total resection by 57% in patients in whom it was used; gross total resection was performed in 56% of patients who underwent surgery with neuronavigation as compared with 35.5% in those who underwent surgery without neuronavigation (risk ratio [RR], 1.57; P=0.056). The incidence of postoperative neurologic deficits (transient and permanent) decreased by 79% with the use of neuronavigation, (12% vs. 33.3%; RR, 0.21; P=0.0003). Neuronavigation improved survival in patients with grade IV gliomas (15 months vs. 13.8 months), but it was not statistically significant (odds ratio (OR), 0.19; P=0.13). CONCLUSIONS: Neuronavigation improved the effectiveness (greater gross total resection of tumors) and safety (fewer neurological deficits) of brain glioma surgery. However, neuronavigation does not significantly influence the survival of patients with grade IV gliomas.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Perera Valdivia D, Zapata Vega L, Herrera Pérez E, et al. Effects of the Use of Neuronavigation in Patients with Supratentorial Brain Gliomas: A Cohort Study. World Neurosurg. 2024. PMID: 38734167. doi:10.1016/j.wneu.2024.05.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。